US Stock MarketDetailed Quotes

CSTL Castle Biosciences

Watchlist
  • 21.680
  • -3.600-14.24%
Close Feb 28 16:00 ET
  • 22.300
  • +0.620+2.86%
Post 19:48 ET
618.19MMarket Cap34.97P/E (TTM)

Castle Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
1,252.97%64.87M
31.09%24.37M
365.64%23.34M
733.86%24M
73.13%-6.84M
86.49%-5.63M
409.78%18.59M
195.94%5.01M
57.94%-3.79M
-18.71%-25.44M
Net income from continuing operations
131.75%18.25M
471.71%9.59M
132.86%2.27M
147.50%8.92M
91.32%-2.53M
14.41%-57.47M
87.49%-2.58M
65.90%-6.91M
-1,039.38%-18.78M
-18.60%-29.2M
Operating gains losses
---555K
----
----
----
----
----
----
----
----
----
Depreciation and amortization
29.74%16M
78.91%5.77M
11.56%3.54M
10.13%3.35M
15.49%3.34M
16.95%12.33M
13.48%3.22M
8.59%3.17M
15.68%3.04M
34.45%2.89M
Deferred tax
728.25%1.4M
-877.54%-2.31M
--5.25M
---1.54M
--0
88.12%-223K
-521.05%-236K
--0
--0
-89.43%13K
Other non cash items
-57.80%268K
-82.91%60K
76.06%125K
-4,900.00%-96K
-15.17%179K
103.50%635K
207.01%351K
1,875.00%71K
100.01%2K
-91.80%211K
Change In working capital
-113.05%-14.13M
-74.13%1.98M
127.69%776K
1,149.67%1.91M
-61.38%-18.8M
-94,614.29%-6.63M
125.21%7.67M
-190.56%-2.8M
-95.71%153K
-15.61%-11.65M
-Change in receivables
15.32%-12.64M
33.19%-769K
26.67%-4.25M
6.59%-3.36M
2.76%-4.26M
-140.11%-14.93M
-113.15%-1.15M
-11,502.00%-5.8M
-23.84%-3.6M
-60.84%-4.38M
-Change in inventory
95.13%-193K
28.07%-1.56M
309.38%1.44M
77.01%-368K
155.00%297K
-135.83%-3.96M
-1,120.79%-2.17M
180.73%352K
-117.23%-1.6M
-64.13%-540K
-Change in prepaid assets
-162.53%-1.14M
17.51%537K
-31.90%-1.39M
-123.52%-191K
84.25%-103K
64.46%-435K
-29.26%457K
9.72%-1.05M
332.00%812K
-83.19%-654K
-Change in payables and accrued expense
-103.56%-442K
-65.23%3.59M
29.60%5.26M
12.48%5.3M
-119.27%-14.59M
53.23%12.43M
228.25%10.32M
-11.22%4.06M
-33.67%4.71M
0.73%-6.65M
-Change in other current assets
369.39%1.58M
35.01%617K
129.44%146K
159.47%713K
-83.38%108K
-136.54%-588K
19.63%457K
-273.43%-496K
-277.10%-1.2M
146.21%650K
-Change in other current liabilities
-251.29%-1.29M
-76.76%-426K
-419.26%-431K
-117.74%-182K
-267.65%-250K
240.13%852K
-391.84%-241K
218.42%135K
568.49%1.03M
69.91%-68K
Cash from discontinued investing activities
Operating cash flow
1,252.97%64.87M
31.09%24.37M
365.64%23.34M
733.86%24M
73.13%-6.84M
86.49%-5.63M
409.78%18.59M
195.94%5.01M
57.94%-3.79M
-18.71%-25.44M
Investing cash flow
Cash flow from continuing investing activities
-209.81%-50.14M
175.21%5.77M
-52.34%-14.79M
-39.19%-21.42M
-218.80%-19.7M
90.28%-16.18M
-71.17%-7.67M
92.76%-9.71M
44.07%-15.39M
4,225.37%16.58M
Net PPE purchase and sale
-108.02%-28.31M
-99.47%-7.56M
-159.85%-6.37M
-29.64%-5.23M
-174.44%-9.15M
-150.29%-13.61M
-136.73%-3.79M
-20.42%-2.45M
-188.62%-4.03M
-729.10%-3.33M
Net business purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
-747.73%-21.83M
443.38%13.33M
-15.99%-8.42M
-42.58%-16.19M
-152.99%-10.55M
98.09%-2.58M
-34.74%-3.88M
94.50%-7.26M
---11.36M
--19.92M
Cash from discontinued investing activities
Investing cash flow
-209.81%-50.14M
175.21%5.77M
-52.34%-14.79M
-39.19%-21.42M
-218.80%-19.7M
90.28%-16.18M
-71.17%-7.67M
92.76%-9.71M
44.07%-15.39M
4,225.37%16.58M
Financing cash flow
Cash flow from continuing financing activities
367.15%6.14M
-63.33%-5.39M
1,762.22%838K
-81.42%42K
1,362.09%10.64M
-251.68%-2.3M
-339.60%-3.3M
-88.40%45K
-65.81%226K
-40.13%728K
Net issuance payments of debt
7,073.94%9.9M
27.78%-26K
33.33%-24K
68.57%-11K
28,568.57%9.96M
-16.39%-142K
-5.88%-36K
-9.09%-36K
-12.90%-35K
-45.83%-35K
Proceeds from stock option exercised by employees
67.83%5M
35.28%1.02M
512.50%2.16M
-15.97%668K
7.15%1.15M
-10.44%2.98M
-10.02%754K
-24.63%352K
9.81%795K
-16.90%1.08M
Net other financing activities
-70.67%-8.76M
-58.88%-6.38M
-377.49%-1.29M
-15.17%-615K
-50.96%-474K
-204.15%-5.13M
-158.37%-4.02M
-489.13%-271K
-1,568.75%-534K
-460.71%-314K
Cash from discontinued financing activities
Financing cash flow
367.15%6.14M
-63.33%-5.39M
1,762.22%838K
-81.42%42K
1,362.09%10.64M
-251.68%-2.3M
-339.60%-3.3M
-88.40%45K
-65.81%226K
-40.13%728K
Net cash flow
Beginning cash position
-19.61%98.84M
4.10%94.96M
-10.75%85.57M
-27.76%82.95M
-19.61%98.84M
-62.70%122.95M
-32.01%91.22M
-64.90%95.87M
-62.84%114.82M
-62.70%122.95M
Current changes in cash
186.56%20.87M
224.89%24.75M
301.83%9.39M
113.84%2.62M
-95.55%-15.89M
88.34%-24.11M
167.82%7.62M
96.65%-4.65M
47.15%-18.95M
60.58%-8.13M
End cash Position
21.11%119.71M
21.11%119.71M
4.10%94.96M
-10.75%85.57M
-27.76%82.95M
-19.61%98.84M
-19.61%98.84M
-32.01%91.22M
-64.90%95.87M
-62.84%114.82M
Free cash flow
289.85%36.54M
13.55%16.8M
563.28%16.96M
339.98%18.77M
44.45%-15.99M
59.30%-19.25M
289.98%14.79M
135.21%2.56M
24.84%-7.82M
-31.81%-28.78M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 1,252.97%64.87M31.09%24.37M365.64%23.34M733.86%24M73.13%-6.84M86.49%-5.63M409.78%18.59M195.94%5.01M57.94%-3.79M-18.71%-25.44M
Net income from continuing operations 131.75%18.25M471.71%9.59M132.86%2.27M147.50%8.92M91.32%-2.53M14.41%-57.47M87.49%-2.58M65.90%-6.91M-1,039.38%-18.78M-18.60%-29.2M
Operating gains losses ---555K------------------------------------
Depreciation and amortization 29.74%16M78.91%5.77M11.56%3.54M10.13%3.35M15.49%3.34M16.95%12.33M13.48%3.22M8.59%3.17M15.68%3.04M34.45%2.89M
Deferred tax 728.25%1.4M-877.54%-2.31M--5.25M---1.54M--088.12%-223K-521.05%-236K--0--0-89.43%13K
Other non cash items -57.80%268K-82.91%60K76.06%125K-4,900.00%-96K-15.17%179K103.50%635K207.01%351K1,875.00%71K100.01%2K-91.80%211K
Change In working capital -113.05%-14.13M-74.13%1.98M127.69%776K1,149.67%1.91M-61.38%-18.8M-94,614.29%-6.63M125.21%7.67M-190.56%-2.8M-95.71%153K-15.61%-11.65M
-Change in receivables 15.32%-12.64M33.19%-769K26.67%-4.25M6.59%-3.36M2.76%-4.26M-140.11%-14.93M-113.15%-1.15M-11,502.00%-5.8M-23.84%-3.6M-60.84%-4.38M
-Change in inventory 95.13%-193K28.07%-1.56M309.38%1.44M77.01%-368K155.00%297K-135.83%-3.96M-1,120.79%-2.17M180.73%352K-117.23%-1.6M-64.13%-540K
-Change in prepaid assets -162.53%-1.14M17.51%537K-31.90%-1.39M-123.52%-191K84.25%-103K64.46%-435K-29.26%457K9.72%-1.05M332.00%812K-83.19%-654K
-Change in payables and accrued expense -103.56%-442K-65.23%3.59M29.60%5.26M12.48%5.3M-119.27%-14.59M53.23%12.43M228.25%10.32M-11.22%4.06M-33.67%4.71M0.73%-6.65M
-Change in other current assets 369.39%1.58M35.01%617K129.44%146K159.47%713K-83.38%108K-136.54%-588K19.63%457K-273.43%-496K-277.10%-1.2M146.21%650K
-Change in other current liabilities -251.29%-1.29M-76.76%-426K-419.26%-431K-117.74%-182K-267.65%-250K240.13%852K-391.84%-241K218.42%135K568.49%1.03M69.91%-68K
Cash from discontinued investing activities
Operating cash flow 1,252.97%64.87M31.09%24.37M365.64%23.34M733.86%24M73.13%-6.84M86.49%-5.63M409.78%18.59M195.94%5.01M57.94%-3.79M-18.71%-25.44M
Investing cash flow
Cash flow from continuing investing activities -209.81%-50.14M175.21%5.77M-52.34%-14.79M-39.19%-21.42M-218.80%-19.7M90.28%-16.18M-71.17%-7.67M92.76%-9.71M44.07%-15.39M4,225.37%16.58M
Net PPE purchase and sale -108.02%-28.31M-99.47%-7.56M-159.85%-6.37M-29.64%-5.23M-174.44%-9.15M-150.29%-13.61M-136.73%-3.79M-20.42%-2.45M-188.62%-4.03M-729.10%-3.33M
Net business purchase and sale --0------------------0----------------
Net investment purchase and sale -747.73%-21.83M443.38%13.33M-15.99%-8.42M-42.58%-16.19M-152.99%-10.55M98.09%-2.58M-34.74%-3.88M94.50%-7.26M---11.36M--19.92M
Cash from discontinued investing activities
Investing cash flow -209.81%-50.14M175.21%5.77M-52.34%-14.79M-39.19%-21.42M-218.80%-19.7M90.28%-16.18M-71.17%-7.67M92.76%-9.71M44.07%-15.39M4,225.37%16.58M
Financing cash flow
Cash flow from continuing financing activities 367.15%6.14M-63.33%-5.39M1,762.22%838K-81.42%42K1,362.09%10.64M-251.68%-2.3M-339.60%-3.3M-88.40%45K-65.81%226K-40.13%728K
Net issuance payments of debt 7,073.94%9.9M27.78%-26K33.33%-24K68.57%-11K28,568.57%9.96M-16.39%-142K-5.88%-36K-9.09%-36K-12.90%-35K-45.83%-35K
Proceeds from stock option exercised by employees 67.83%5M35.28%1.02M512.50%2.16M-15.97%668K7.15%1.15M-10.44%2.98M-10.02%754K-24.63%352K9.81%795K-16.90%1.08M
Net other financing activities -70.67%-8.76M-58.88%-6.38M-377.49%-1.29M-15.17%-615K-50.96%-474K-204.15%-5.13M-158.37%-4.02M-489.13%-271K-1,568.75%-534K-460.71%-314K
Cash from discontinued financing activities
Financing cash flow 367.15%6.14M-63.33%-5.39M1,762.22%838K-81.42%42K1,362.09%10.64M-251.68%-2.3M-339.60%-3.3M-88.40%45K-65.81%226K-40.13%728K
Net cash flow
Beginning cash position -19.61%98.84M4.10%94.96M-10.75%85.57M-27.76%82.95M-19.61%98.84M-62.70%122.95M-32.01%91.22M-64.90%95.87M-62.84%114.82M-62.70%122.95M
Current changes in cash 186.56%20.87M224.89%24.75M301.83%9.39M113.84%2.62M-95.55%-15.89M88.34%-24.11M167.82%7.62M96.65%-4.65M47.15%-18.95M60.58%-8.13M
End cash Position 21.11%119.71M21.11%119.71M4.10%94.96M-10.75%85.57M-27.76%82.95M-19.61%98.84M-19.61%98.84M-32.01%91.22M-64.90%95.87M-62.84%114.82M
Free cash flow 289.85%36.54M13.55%16.8M563.28%16.96M339.98%18.77M44.45%-15.99M59.30%-19.25M289.98%14.79M135.21%2.56M24.84%-7.82M-31.81%-28.78M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
LINTEX
920106
+30.00%
LINGOOD
833284
+29.98%
NTGEC
870436
+29.98%
4
CG MED EQUIP.
838810
+29.97%
5
Jiayu Holding
300117
+20.48%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Widespread uptick! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. Chinese stocks l Show More
Chinese Stocks' Wild Rally Hits Pause? Wall Street Still Bets Big on Favorites